Colchicine Dosing for Acute Gout in Patients with Normal Renal Function
Recommended Treatment Regimen
For a patient with normal renal function experiencing an acute gout attack, administer colchicine 1.2 mg (2 tablets of 500 mcg) immediately at the first sign of flare, followed by 0.6 mg (1 tablet) one hour later, then continue with 0.6 mg twice daily until the attack resolves, typically within a few days. 1, 2
Initial Loading Dose (Day 1)
- Take 1.2 mg (2 tablets) immediately at the first sign of gout symptoms 1, 2
- Take 0.6 mg (1 tablet) one hour later 1, 2
- This low-dose regimen (total 1.8 mg over 1 hour) is as effective as the older high-dose regimen (4.8 mg over 6 hours) but with significantly fewer gastrointestinal side effects 1, 3
Maintenance Dosing (After Initial Loading)
- Wait 12 hours after the initial loading doses before resuming any further colchicine 1
- Continue with 0.6 mg twice daily (or 0.6 mg once daily if better tolerated) until the acute attack completely resolves 1, 4
- Treatment duration is typically a few days to one week 1
Critical Timing Window
- Treatment must be initiated within 36 hours of symptom onset for maximum effectiveness 1, 4
- Colchicine is most effective when started within 12 hours of the first symptoms 1
- Delaying treatment beyond 36 hours significantly reduces efficacy 1, 4
Important Safety Counseling
Gastrointestinal Toxicity
- Stop colchicine immediately and seek medical attention if severe diarrhea, vomiting, or abdominal pain develops 1, 2
- The low-dose regimen has a safety profile similar to placebo, with only 23% experiencing diarrhea compared to 77% with high-dose regimens 3
- All patients on the older high-dose regimens experienced gastrointestinal side effects 5, 6
Drug Interactions
- Avoid grapefruit and grapefruit juice, as they inhibit CYP3A4 and can increase colchicine toxicity 1, 2
- Colchicine is absolutely contraindicated with strong CYP3A4 or P-glycoprotein inhibitors (clarithromycin, erythromycin, cyclosporine, ritonavir, ketoconazole) in patients with any renal or hepatic impairment 1, 2
- Even in patients with normal renal function, dose reduction is required when taking moderate CYP3A4 inhibitors 2
Common Pitfalls to Avoid
- Never use the obsolete high-dose regimen (0.5 mg every 2 hours until relief or toxicity), which causes severe diarrhea in most patients with no additional benefit 5, 1
- Do not repeat the loading dose within 36 hours - if already on prophylactic colchicine when the attack occurs, take the loading dose but wait 12 hours before resuming prophylactic dosing 1
- Do not continue the twice-daily dosing indefinitely - stop once the acute attack resolves, typically within days 1, 4
Evidence Quality
- The recommended low-dose regimen is supported by the AGREE trial, a high-quality randomized controlled trial showing equal efficacy to high-dose colchicine with a number needed to treat (NNT) of 5 for achieving ≥50% pain reduction at 24 hours 1, 3
- This regimen is endorsed by the American College of Rheumatology, European League Against Rheumatism, and FDA drug labeling 1, 2